Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Astermark

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Seminars in Hematology|May 13, 2006
Overview of inhibitorsJan Astermark
Blood|February 26, 2015
FVIII inhibitors: pathogenesis and avoidanceJan Astermark
Thrombosis Research|November 9, 2010
Immune tolerance induction in patients with hemophilia AJan Astermark
Seminars in Thrombosis and Hemostasis|March 18, 2003
Treatment of the bleeding inhibitor patientJan Astermark
European Journal of Haematology|January 7, 2015
Genetic risk factors for inhibitors in haemophilia AEdit Bardi, Jan Astermark
European Journal of Haematology|January 7, 2015
Strategies for reducing inhibitor formation in severe haemophiliaOliver Tunstall, Jan Astermark
British Journal of Haematology|October 28, 2010
Combination of FVIII and by-passing agent potentiates in vitro thrombin production in haemophilia A inhibitor plasmaJenny Klintman, Jan Astermark, Erik Berntorp
British Journal of Haematology|October 31, 2002
Antibodies to factor VIIa in patients with haemophilia and high-responding inhibitorsJan Astermark, Maj Ekman, Erik Berntorp
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 22, 2021
Recombinant FVIIa in elective non-orthopaedic surgery of adults with haemophilia and inhibitors: A systematic literature reviewGerard Dolan, Jan Astermark, Cedric Hermans
European Journal of Haematology|January 7, 2012
Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of lifeMohammed Khawaji, Jan Astermark, Erik Berntorp
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Seminars in Hematology|May 13, 2006
Overview of inhibitorsJan Astermark
Blood|February 26, 2015
FVIII inhibitors: pathogenesis and avoidanceJan Astermark
Thrombosis Research|November 9, 2010
Immune tolerance induction in patients with hemophilia AJan Astermark
Seminars in Thrombosis and Hemostasis|March 18, 2003
Treatment of the bleeding inhibitor patientJan Astermark
European Journal of Haematology|January 7, 2015
Genetic risk factors for inhibitors in haemophilia AEdit Bardi, Jan Astermark
European Journal of Haematology|January 7, 2015
Strategies for reducing inhibitor formation in severe haemophiliaOliver Tunstall, Jan Astermark
British Journal of Haematology|October 28, 2010
Combination of FVIII and by-passing agent potentiates in vitro thrombin production in haemophilia A inhibitor plasmaJenny Klintman, Jan Astermark, Erik Berntorp
British Journal of Haematology|October 31, 2002
Antibodies to factor VIIa in patients with haemophilia and high-responding inhibitorsJan Astermark, Maj Ekman, Erik Berntorp
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 22, 2021
Recombinant FVIIa in elective non-orthopaedic surgery of adults with haemophilia and inhibitors: A systematic literature reviewGerard Dolan, Jan Astermark, Cedric Hermans
European Journal of Haematology|January 7, 2012
Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of lifeMohammed Khawaji, Jan Astermark, Erik Berntorp
Pageof 10